The need for a more effective and systemic strategy for oncological treatment was the focus of a discussion held at the headquarters of Employers of Poland among representatives of the medical sector, government and pharmaceutical companies. The debate was organized on the occasion of the publication of a report entitled “Innovative medical therapies” commissioned by the Pharmaceutical Platform of Employers of Poland. The report lists many areas requiring urgent intervention on the part of regulators, central and regional administration, NFZ and other healthcare institutions.
Every year Polish economy loses nearly 17 bln PLN due to malignant cancer. Such where the costs caused in 2013 by premature deaths, inability to work and the hiring of informal caretakers. It is estimated that by 2025, these costs will have risen from the current level of 1 percent of the GDP to 1.3 percent.
Enclosed below you will find the report a presentation on it and a press release (all documents in Polish).
Click here to watch a video (in Polish) with Grzegorz Byszewski, healthcare expert of Employers of Poland.